Expand BTAI Menu
BTAI MENU

BTAI Latest Press Releases

-- January 20, 2026 --

BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI Label Expansion in the At-Home Setting Globe Newswire 7:00 AM

-- January 15, 2026 --

Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights Business Wire 12:44 PM

-- January 12, 2026 --

BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI in the At-Home Setting Globe Newswire 7:00 AM

-- January 7, 2026 --

BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI Globe Newswire 7:00 AM

-- December 3, 2025 --

Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric Conditions Globe Newswire 7:00 AM

-- November 12, 2025 --

BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer's Disease Globe Newswire 7:00 AM

-- October 24, 2025 --

Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights Business Wire 11:38 AM

-- October 14, 2025 --

BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes Globe Newswire 7:00 AM

-- October 13, 2025 --

BioXcel Therapeutics to Ring Nasdaq Closing Bell on October 14 to Celebrate a Transformative Milestone in Neuroscience Innovation Globe Newswire 7:00 AM

-- September 18, 2025 --

BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements Globe Newswire 7:00 AM

-- September 10, 2025 --

BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia Globe Newswire 6:30 AM

-- September 4, 2025 --

BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes